<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "1: Risk Factors", fill: "#1c39bb"},
{source: "1: Risk Factors", target: "2: most significant risk factors applicable", fill: "#bf00ff"},
{source: "2: most significant risk factors applicable", target: "2: impacted by", fill: "#bf00ff"},
{source: "2: impacted by", target: "2: worldwide economic", fill: "#bf00ff"},
{source: "2: worldwide economic", target: "2: conditions", fill: "#bf00ff"},
{source: "2: most significant risk factors applicable", target: "3: The Company ", fill: "#8c92ac"},
{source: "3: The Company ", target: "3: approximately", fill: "#8c92ac"},
{source: "3: approximately", target: "3: revenues from outside", fill: "#8c92ac"},
{source: "3: revenues from outside", target: "3: United States", fill: "#8c92ac"},
{source: "3: The Company ", target: "4: affected by factors", fill: "#0093af"},
{source: "4: affected by factors", target: "4: United States ", fill: "#0093af"},
{source: "4: United States ", target: "4: control such as downturns", fill: "#0093af"},
{source: "4: control such as downturns", target: "4: specific country", fill: "#0093af"},
{source: "4: specific country", target: "4: various industries", fill: "#0093af"},
{source: "4: various industries", target: "4: social political", fill: "#0093af"},
{source: "4: social political", target: "4: labor conditions", fill: "#0093af"},
{source: "4: labor conditions", target: "4: potential adverse", fill: "#0093af"},
{source: "4: potential adverse", target: "4: jurisdictions", fill: "#0093af"},
{source: "4: affected by factors", target: "6: Demand for the Companys ", fill: "#ec3b83"},
{source: "6: Demand for the Companys ", target: "6: products which impacts revenue", fill: "#ec3b83"},
{source: "6: products which impacts revenue", target: "6: development", fill: "#ec3b83"},
{source: "6: development", target: "6: introduction", fill: "#ec3b83"},
{source: "6: introduction", target: "6: competitive products ii", fill: "#ec3b83"},
{source: "6: competitive products ii", target: "6: Companys ", fill: "#ec3b83"},
{source: "6: Companys ", target: "6: stay competitive iii", fill: "#ec3b83"},
{source: "6: stay competitive iii", target: "6: patterns such as", fill: "#ec3b83"},
{source: "6: patterns such as", target: "6: by customers", fill: "#ec3b83"},
{source: "6: by customers", target: "6: customer purchases which may", fill: "#ec3b83"},
{source: "6: customer purchases which may", target: "6: affected by", fill: "#ec3b83"},
{source: "6: affected by", target: "6: Companys ", fill: "#ec3b83"},
{source: "6: Companys ", target: "6: incentive programs", fill: "#ec3b83"},
{source: "6: incentive programs", target: "6: incentive goals", fill: "#ec3b83"},
{source: "6: incentive goals", target: "6: customers preferences", fill: "#ec3b83"},
{source: "6: customers preferences", target: "6: Companys ", fill: "#ec3b83"},
{source: "6: Demand for the Companys ", target: "7: currency exchange rates", fill: "#a8e4a0"},
{source: "7: currency exchange rates", target: "7: fluctuations", fill: "#a8e4a0"},
{source: "7: fluctuations", target: "7: rates may affect", fill: "#a8e4a0"},
{source: "7: rates may affect", target: "7: Companys ", fill: "#a8e4a0"},
{source: "7: Companys ", target: "7: growth rates", fill: "#a8e4a0"},
{source: "7: currency exchange rates", target: "8: Because the Company ", fill: "#fdfd96"},
{source: "8: Because the Company ", target: "8: revenues from", fill: "#fdfd96"},
{source: "8: revenues from", target: "8: United States ", fill: "#fdfd96"},
{source: "8: United States ", target: "8: growth rates", fill: "#fdfd96"},
{source: "8: growth rates", target: "8: adversely affected", fill: "#fdfd96"},
{source: "8: Because the Company ", target: "9: The Companys ", fill: "#522d80"},
{source: "9: The Companys ", target: "9: growth objectives", fill: "#522d80"},
{source: "9: growth objectives", target: "9: largely dependent on", fill: "#522d80"},
{source: "9: largely dependent on", target: "9: new product offerings", fill: "#522d80"},
{source: "9: new product offerings", target: "9: new products", fill: "#522d80"},
{source: "9: The Companys ", target: "10: ability may", fill: "#ef3038"},
{source: "10: ability may", target: "10: adversely affected by difficulties", fill: "#ef3038"},
{source: "10: adversely affected by difficulties", target: "10: development such as", fill: "#ef3038"},
{source: "10: development such as", target: "10: inability", fill: "#ef3038"},
{source: "10: inability", target: "10: viable new products", fill: "#ef3038"},
{source: "10: viable new products", target: "10: successfully", fill: "#ef3038"},
{source: "10: successfully", target: "10: clinical trials", fill: "#ef3038"},
{source: "10: clinical trials", target: "10: regulatory", fill: "#ef3038"},
{source: "10: ability may", target: "11: pharmaceutical", fill: "#0ff"},
{source: "11: pharmaceutical", target: "11: development", fill: "#0ff"},
{source: "11: development", target: "11: pharmaceutical under development face", fill: "#0ff"},
{source: "11: pharmaceutical under development face", target: "11: uncertainties", fill: "#0ff"},
{source: "11: uncertainties", target: "11: regulatory review", fill: "#0ff"},
{source: "11: pharmaceutical", target: "13: The Companys ", fill: "#253529"},
{source: "13: The Companys ", target: "13: fluctuations", fill: "#253529"},
{source: "13: fluctuations", target: "13: availability", fill: "#253529"},
{source: "13: availability", target: "13: purchased components compounds raw materials", fill: "#253529"},
{source: "13: purchased components compounds raw materials", target: "13: natural gas", fill: "#253529"},
{source: "13: natural gas", target: "13: derivatives due", fill: "#253529"},
{source: "13: derivatives due", target: "13: disasters", fill: "#253529"},
{source: "13: The Companys ", target: "14: The Company ", fill: "#002366"},
{source: "14: The Company ", target: "14: depends on various components", fill: "#002366"},
{source: "14: depends on various components", target: "14: compounds raw materials", fill: "#002366"},
{source: "14: compounds raw materials", target: "14: manufacturing", fill: "#002366"},
{source: "14: manufacturing", target: "14: supplier relationships could", fill: "#002366"},
{source: "14: supplier relationships could", target: "14: interrupted", fill: "#002366"},
{source: "14: interrupted", target: "14: disasters", fill: "#002366"},
{source: "14: The Company ", target: "15: sustained interruption", fill: "#76ff7a"},
{source: "15: sustained interruption", target: "15: Companys ", fill: "#76ff7a"},
{source: "15: Companys ", target: "15: adequate supplies could", fill: "#76ff7a"},
{source: "15: sustained interruption", target: "16: addition while", fill: "#ef98aa"},
{source: "16: addition while", target: "16: minimize volatility", fill: "#ef98aa"},
{source: "16: minimize volatility", target: "16: pricing no assurance", fill: "#ef98aa"},
{source: "16: pricing no assurance", target: "16: successfully manage price fluctuations", fill: "#ef98aa"},
{source: "16: successfully manage price fluctuations", target: "16: future price fluctuations", fill: "#ef98aa"},
{source: "16: future price fluctuations", target: "16: shortages will", fill: "#ef98aa"},
{source: "16: addition while", target: "17: Acquisitions ", fill: "#967bb6"},
{source: "17: Acquisitions ", target: "17: strategic alliances divestitures", fill: "#967bb6"},
{source: "17: strategic alliances divestitures", target: "17: unusual events", fill: "#967bb6"},
{source: "17: unusual events", target: "17: from portfolio management actions", fill: "#967bb6"},
{source: "17: Acquisitions ", target: "18: The Company ", fill: "#cfb53b"},
{source: "18: The Company ", target: "18: organizational", fill: "#cfb53b"},
{source: "18: organizational", target: "18: may continue", fill: "#cfb53b"},
{source: "18: may continue", target: "18: acquisitions strategic", fill: "#cfb53b"},
{source: "18: acquisitions strategic", target: "18: alliances divestitures", fill: "#cfb53b"},
{source: "18: alliances divestitures", target: "18: organizational structure", fill: "#cfb53b"},
{source: "18: The Company ", target: "19: With ", fill: "#746cc0"},
{source: "19: With ", target: "19: acquisitions future", fill: "#746cc0"},
{source: "19: acquisitions future", target: "19: affected by", fill: "#746cc0"},
{source: "19: affected by", target: "19: Companys ", fill: "#746cc0"},
{source: "19: Companys ", target: "19: quickly integrate", fill: "#746cc0"},
{source: "19: With ", target: "23: affected by various legal", fill: "#ff9f00"},
{source: "23: affected by various legal", target: "23: regulatory", fill: "#ff9f00"},
{source: "23: regulatory", target: "23: proceedings", fill: "#ff9f00"},
{source: "23: proceedings", target: "23: involving product liability", fill: "#ff9f00"},
{source: "23: involving product liability", target: "23: antitrust", fill: "#ff9f00"},
{source: "23: antitrust", target: "23: environmental", fill: "#ff9f00"},
{source: "23: affected by various legal", target: "24: proceedings may differ from", fill: "#0070ff"},
{source: "24: proceedings may differ from", target: "24: Companys ", fill: "#0070ff"},
{source: "24: Companys ", target: "24: expectations", fill: "#0070ff"},
{source: "24: expectations", target: "24: litigation", fill: "#0070ff"},
{source: "24: litigation", target: "24: regulatory matters", fill: "#0070ff"},
{source: "24: regulatory matters", target: "24: often difficult", fill: "#0070ff"},
{source: "24: proceedings may differ from", target: "26: future adverse ruling settlement", fill: "#c0c"},
{source: "26: future adverse ruling settlement", target: "26: unfavorable development could", fill: "#c0c"},
{source: "26: unfavorable development could", target: "26: future charges", fill: "#c0c"},
{source: "26: future charges", target: "26: Companys ", fill: "#c0c"},
{source: "26: Companys ", target: "26: operations", fill: "#c0c"},
{source: "26: operations", target: "26: cash flows", fill: "#c0c"},
{source: "26: future adverse ruling settlement", target: "27: could increase", fill: "#6d9bc3"},
{source: "27: could increase", target: "27: Companys ", fill: "#6d9bc3"},
{source: "27: Companys ", target: "27: Congressional ", fill: "#6d9bc3"},
{source: "27: Congressional ", target: "27: consideration", fill: "#6d9bc3"},
{source: "27: consideration", target: "27: legislation", fill: "#6d9bc3"},
{source: "27: legislation", target: "27: litigation", fill: "#6d9bc3"},
{source: "27: litigation", target: "27: derived from", fill: "#6d9bc3"},
{source: "27: could increase", target: "28: legal proceedings involving", fill: "#f5f5dc"},
{source: "28: legal proceedings involving", target: "28: of the Company ", fill: "#f5f5dc"},
{source: "28: of the Company ", target: "28: accounting", fill: "#f5f5dc"},
{source: "28: accounting", target: "28: Consolidated Financial Statements ", fill: "#f5f5dc"},
{source: "28: Consolidated Financial Statements ", target: "28: Annual Report ", fill: "#f5f5dc"},
{source: "28: legal proceedings involving", target: "START_HERE", fill: "#f5f5dc"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Environmental Services</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Ease</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Reward</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Release or return</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Colorectal_cancer">Colorectal cancer</a></td>
      <td>Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum (parts of the large intestine). Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and fatigue.Most colorectal cancers are due to old age and lifestyle factors, with only a small number of cases due to underlying genetic disorders.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Osteoporosis">Osteoporosis</a></td>
      <td>Osteoporosis is a systemic skeletal disorder characterized by low bone mass, micro-architectural deterioration of bone tissue leading to bone fragility, and consequent increase in fracture risk. It is the most common reason for a broken bone among the elderly.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Earwax">Earwax</a></td>
      <td>Earwax, also known by the medical term cerumen, is a brown, orange, red, yellowish or gray waxy substance secreted in the ear canal of humans and other mammals.  It protects the skin of the human ear canal, assists in cleaning and lubrication, and provides protection against bacteria, fungi, and water.Earwax consists of dead skin cells, hair, and the secretions of cerumen by the ceruminous and sebaceous glands of the outer ear canal.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/1997_Asian_financial_crisis">1997 Asian financial crisis</a></td>
      <td>The Asian financial crisis was a period of financial crisis that gripped much of East Asia and Southeast Asia beginning in July 1997 and raised fears of a worldwide economic meltdown due to financial contagion. However, the recovery in 1998–1999 was rapid and worries of a meltdown subsided.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Longaberger_Company">The Longaberger Company</a></td>
      <td>The Longaberger Company is an American manufacturer and distributor of handcrafted maple wood baskets and other home and lifestyle products. The company opened in 1973, was acquired in 2013 by CVSL, Inc., and closed in 2018.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Approximation">Approximation</a></td>
      <td>An approximation is anything that is intentionally similar but not exactly equal to something else.\n\n\n== Etymology and usage ==\nThe word approximation is derived from Latin approximatus, from proximus meaning very near and the prefix ad- (ad- before p becomes ap- by assimilation) meaning to.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Probably_approximately_correct_learning">Probably approximately correct learning</a></td>
      <td>In computational learning theory, probably approximately correct (PAC) learning is a framework for mathematical analysis of machine learning. It was proposed in 1984 by Leslie Valiant.In this framework, the learner receives samples and must select a generalization function (called the hypothesis) from a certain class of possible functions.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Vegetarianism_by_country">Vegetarianism by country</a></td>
      <td>Vegetarian and vegan dietary practices vary among countries. Differences include food standards, laws, and general cultural attitudes toward vegetarian diets.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Introduction_(music)">Introduction (music)</a></td>
      <td>In music, the introduction is a passage or section which opens a movement or a separate piece, preceding the theme or lyrics. In popular music, this is often known as the song intro or just the intro.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Customer_satisfaction">Customer satisfaction</a></td>
      <td>Customer satisfaction (often abbreviated as CSAT) is a term frequently used in marketing. It is a measure of how products and services supplied by a company meet or surpass customer expectation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Affective_computing">Affective computing</a></td>
      <td>Affective computing is the study and development of systems and devices that can recognize, interpret, process, and simulate human affects. It is an interdisciplinary field spanning computer science, psychology, and cognitive science.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Decree_nisi">Decree nisi</a></td>
      <td>A decree nisi or rule nisi (from Latin  nisi 'unless') is a court order that will come into force at a future date unless a particular condition is met. Unless the condition is met, the ruling becomes a decree absolute (rule absolute), and is binding.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Fantastic_Sams">Fantastic Sams</a></td>
      <td>Fantastic Sams Holding Corp. is an American full-service haircare franchise (Fantastic Sams Cut &amp; Color) in U.S. and Canada who pioneered the concept of a no-appointment, walk-in hair salon.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Pietro_Torrigiano">Pietro Torrigiano</a></td>
      <td>Pietro Torrigiano (24 November 1472 – July/August 1528) was an Italian Renaissance sculptor from Florence, who had to flee the city after breaking Michelangelo's nose. He then worked abroad, and died in prison in Spain.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Human_Development_Index">Human Development Index</a></td>
      <td>The Human Development Index (HDI) is a statistic composite index of life expectancy, education (mean years of schooling completed and expected years of schooling upon entering the education system), and per capita income indicators, which are used to rank countries into four tiers of human development. A country scores a higher level of HDI when the lifespan is higher, the education level is higher, and the gross national income GNI (PPP) per capita is higher.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_countries_by_Human_Development_Index">List of countries by Human Development Index</a></td>
      <td>The United Nations Development Programme (UNDP) compiles the Human Development Index (HDI) of 189 nations in the annual Human Development Report. The index considers the health, education and income in a given country to provide a measure of human development which is comparable between countries and over time.The HDI was first published in 1990 with the goal of being a more comprehensive measure of human development than purely economic measures such as gross domestic product.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Analysis_of_clinical_trials">Analysis of clinical trials</a></td>
      <td>The analysis of clinical trials involves many related topics including:\n\nthe choice of an estimand (measure of effect size) of interest that is closely linked to the objectives of the trial,\nthe choice and definition of analysis sets,\nthe choice of an appropriate statistical model for the type of data being studied,\nappropriate accounting for the treatment assignment process,\nhandling of missing data,\nhandling of multiple comparisons or endpoints,\naccounting for interim analyses and trial adaptations,\nand appropriate data presentation.One basic guidance document on this topic is the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use guidance E9.\n\n\n== Choice of analysis set ==\nFailure to include all participants in the analysis may bias the trial results.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Uncertainty_budget">Uncertainty budget</a></td>
      <td>The uncertainty budget is an aid for specifying the expanded measurement uncertainty. The individual measurement uncertainty factors are summarised, usually in tabular form, in the measurement uncertainty budget.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Available-to-promise">Available-to-promise</a></td>
      <td>Available-to-promise (ATP) is a business function that provides a response to customer order inquiries, based on resource availability.\n It generates available quantities of the requested product, and delivery due dates.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Component_Manager">Component Manager</a></td>
      <td>In Apple Macintosh computer programming, Component Manager was one of many approaches to sharing code that originated on the pre-PowerPC Macintosh. It was originally introduced as part of QuickTime, which remained the part of the classic Mac OS that used it most heavily.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Tig_Notaro">Tig Notaro</a></td>
      <td>Mathilde O'Callaghan "Tig" Notaro (born March 24, 1971) is an American stand-up comedian, writer, radio contributor, and actress. She is known for her deadpan comedy.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Battle_of_Isurava">Battle of Isurava</a></td>
      <td>The Battle of Isurava (also sometimes referred to as the Battle of Isurava – Abuari or the Battle of Isuraba) took place over the period 26 to 31 August 1942. Forming part of the Kokoda Track campaign of the Second World War, the battle involved military forces from Australia, supported by the United States, fighting against Japanese troops from Major General Tomitaro Horii's South Seas Detachment who had landed around Buna and Gona in Papua mid-July 1942, with the intent of capturing Port Moresby to the south via the overland route.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Voulge">Voulge</a></td>
      <td>A voulge (occasionally called a pole cleaver; also spelled vouge) is a type of polearm that existed alongside the similar glaive in medieval Europe. Superficially, a voulge might strongly resemble a glaive, but there are some notable differences in construction.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/2020–present_global_chip_shortage">2020–present global chip shortage</a></td>
      <td>The 2020–present global chip shortage is an ongoing global crisis in which the demand for integrated circuits (commonly known as semiconductor chips) exceeds the supply, affecting more than 169 industries. The crisis has led to major price increases, shortages queues and scalping among consumers for automobiles, graphics cards, video game consoles, computers, and other products that require semiconductors.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bread_Financial">Bread Financial</a></td>
      <td>Bread Financial Holdings, Inc. (formerly the Alliance Data Systems Corporation) is a publicly traded provider of loyalty and marketing services, such as private label credit cards, coalition loyalty programs, and direct marketing, derived from the capture and analysis of transaction-rich data.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Attempted_acquisition_of_Tribune_Media_by_Sinclair_Broadcast_Group">Attempted acquisition of Tribune Media by Sinclair Broadcast Group</a></td>
      <td>The attempted acquisition of Tribune Media by Sinclair Broadcast Group was a proposed broadcast media transaction between Sinclair Broadcast Group and Tribune Media. Formally announced on May 8, 2017, the $3.9 billion deal would have resulted in Sinclair owning—or having operational control over—stations available in 72% of all households with a television set in the United States.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/General_Electric_timeline">General Electric timeline</a></td>
      <td>General Electric has a long history, involving numerous mergers, acquisitions, and divestitures.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/United_States_antitrust_law">United States antitrust law</a></td>
      <td>In the United States, antitrust law is a collection of mostly federal laws that regulate the conduct and organization of businesses to promote competition and prevent unjustified monopolies. The main statutes are the Sherman Act of 1890, the Clayton Act of 1914 and the Federal Trade Commission Act of 1914.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Clayton_Antitrust_Act_of_1914">Clayton Antitrust Act of 1914</a></td>
      <td>The Clayton Antitrust Act of 1914 (Pub.L. 63–212, 38 Stat. 730, enacted October 15, 1914, codified at 15 U.S.C. §§ 12–27, 29 U.S.C. §§ 52–53), is a part of United States antitrust law with the goal of adding further substance to the U.S. antitrust law regime; the Clayton Act seeks to prevent anticompetitive practices in their incipiency.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Vexatious_litigation">Vexatious litigation</a></td>
      <td>Vexatious litigation is legal action which is brought  solely to harass or subdue an adversary. It may take the form of a primary frivolous lawsuit or may be the repetitive, burdensome, and unwarranted filing of meritless motions in a matter which is otherwise a meritorious cause of action.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Airbnb">Airbnb</a></td>
      <td>Airbnb, Inc. ( AIR-BEE-en-BEE) is an American company that operates an online marketplace for lodging, primarily homestays for vacation rentals, and tourism activities.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Shaped_charge">Shaped charge</a></td>
      <td>A shaped charge is an explosive charge shaped to focus the effect of the explosive's energy. Different types of shaped charges are used for various purposes such as cutting and forming metal, initiating nuclear weapons, penetrating armor, or perforating wells in the oil and gas industry.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Kentucky's_congressional_districts">Kentucky's congressional districts</a></td>
      <td>Kentucky is currently divided into 6 congressional districts, each represented by a member of the United States House of Representatives. The number of congressional districts has been set at 6 since the 1990 redistricting cycle.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Objection_to_the_consideration_of_a_question">Objection to the consideration of a question</a></td>
      <td>In parliamentary procedure, an objection to the consideration of a question is a motion that is adopted to prevent an original main motion from coming before the assembly. This motion is different from an objection to a unanimous consent request.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Rider_(legislation)">Rider (legislation)</a></td>
      <td>In legislative procedure, a rider is an additional provision added to a bill or other measure under the consideration by a legislature, having little connection with the subject matter of the bill.Some scholars identify riders as a specific form of logrolling, or as implicit logrolling. Others distinguish riders from logrolling.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_Comptroller_General_Office_(Nepal)">Financial Comptroller General Office (Nepal)</a></td>
      <td>Financial Comptroller General Office (FCGO) is the main government agency responsible for the treasury operation of Government of Nepal. This office is under the Ministry of Finance and is headed by Financial Comptroller General who is a special class officer of Government of Nepal.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>3M CO      Item 1A <font color="blue">Risk Factors</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">most <font color="blue">significant</font> risk factors applicable</font> to the Company are as follows:         • Results are <font color="blue">impacted by</font> the effects of, and changes in, <font color="blue">worldwide economic</font>     <font color="blue">conditions</font></td>
    </tr>
    <tr>
      <td><font color="blue">The Company </font>operates in more than 60 countries and derives     <font color="blue">approximately</font>  60prca of its <font color="blue"><font color="blue">revenues from</font> outside</font> the <font color="blue">United States</font></td>
    </tr>
    <tr>
      <td>The     Company’s business may be <font color="blue"><font color="blue">affected by</font> factors</font> in the <font color="blue">United States</font> and other     countries  that  are beyond its control, such as downturns in economic     activity in a <font color="blue">specific country</font> or region, or in the <font color="blue">various industries</font> in     which the Company operates; social, political or labor <font color="blue">conditions</font> in a     <font color="blue">specific country</font> or region; or <font color="blue">potential adverse</font> changes in tax in the     <font color="blue">jurisdictions</font> in which the Company operates</td>
    </tr>
    <tr>
      <td>• The Company’s results are <font color="blue">affected by</font> competitive <font color="blue">conditions</font> and customer     <font color="blue">preferences</font></td>
    </tr>
    <tr>
      <td>Demand for the Company’s products, which impacts revenue and     profit  margins,  is  affected  by  (i)  the <font color="blue">development</font> and timing of     <font color="blue">introduction</font>  of  competitive products; (ii) the Company’s response to     downward  pricing to stay competitive; (iii) changes in customer order     patterns, such as changes in the levels of inventory maintained <font color="blue">by customers</font>     and the timing of <font color="blue">customer purchases which may</font> be <font color="blue">affected by</font> announced     price  changes,  changes  in  the Company’s <font color="blue">incentive programs</font>, or the     customer’s  ability  to  achieve <font color="blue">incentive goals</font> ; and (iv) changes in     customers’ <font color="blue">preferences</font> for our products, including changes in customer     designs  for their products that can affect the demand for some of the     Company’s products</td>
    </tr>
    <tr>
      <td>• Foreign <font color="blue">currency exchange rates</font> and <font color="blue">fluctuations</font> in those <font color="blue">rates may affect</font>     the Company’s ability to realize projected <font color="blue">growth rates</font> in its sales and     earnings</td>
    </tr>
    <tr>
      <td><font color="blue">Because the Company </font>derives <font color="blue">approximately</font> 60prca of its <font color="blue">revenues from</font>     outside the <font color="blue">United States</font>, its ability to realize projected <font color="blue">growth rates</font> in     sales  and  earnings  could  be  <font color="blue">adversely affected</font> if the US dollar     strengthens <font color="blue">significant</font>ly against foreign currencies</td>
    </tr>
    <tr>
      <td>• The Company’s <font color="blue">growth objectives</font> are <font color="blue">largely dependent on</font> the timing and     market acceptance of its <font color="blue">new product offerings</font>, including its ability to     renew its pipeline of <font color="blue">new products</font> and to bring those products to market</td>
    </tr>
    <tr>
      <td>This <font color="blue">ability may</font> be adversely <font color="blue">affected by</font> difficulties or delays in product     <font color="blue">development</font>, such as the <font color="blue">inability</font> to: identify viable <font color="blue">new products</font>; obtain     adequate intellectual property protection; gain market acceptance of new     products; or <font color="blue">successfully</font> complete <font color="blue">clinical trials</font> and obtain <font color="blue">regulatory</font>     approvals</td>
    </tr>
    <tr>
      <td>For  example,  new  3M  <font color="blue">pharmaceutical</font>  products, like any     <font color="blue">pharmaceutical</font> under <font color="blue">development</font>, face substantial risks and <font color="blue">uncertainties</font>     in the process of <font color="blue">development</font> and <font color="blue">regulatory</font> review</td>
    </tr>
    <tr>
      <td>There are <font color="blue">no guarantees</font>     that <font color="blue">new products</font> will prove to be <font color="blue">commercially successful</font></td>
    </tr>
    <tr>
      <td>• The Company’s future results are subject to <font color="blue">fluctuations</font> in the costs and     <font color="blue">availability</font> of purchased components, compounds, raw materials and energy,     including oil and <font color="blue">natural gas</font> and their derivatives, due to shortages,     increased demand, supply interruptions, currency exchange risks, natural     <font color="blue">disasters</font> and other factors</td>
    </tr>
    <tr>
      <td><font color="blue">The Company </font><font color="blue">depends on various components</font>,     compounds, raw materials, and energy (including oil and <font color="blue">natural gas</font> and     their derivatives) supplied by others for the <font color="blue">manufacturing</font> of its products     and  it  is  possible  that any of its <font color="blue">supplier relationships could</font> be     <font color="blue">interrupted</font>  due  to  natural  and other <font color="blue">disasters</font> and other events or     terminated  in the future</td>
    </tr>
    <tr>
      <td>Any <font color="blue">sustained interruption</font> in the Company’s     receipt of <font color="blue">adequate supplies could</font> have a material adverse effect on the     Company</td>
    </tr>
    <tr>
      <td>In addition, while the Company has a process to <font color="blue">minimize volatility</font>     in  component and material pricing, no assurance can be given that the     Company will be able to <font color="blue">successfully</font> manage price <font color="blue">fluctuations</font> or that     future price <font color="blue">fluctuations</font> or <font color="blue">shortages will</font> not have a material adverse     effect on the Company</td>
    </tr>
    <tr>
      <td>• Acquisitions, strategic alliances, divestitures, and other <font color="blue">unusual events</font>     resulting <font color="blue">from portfolio management actions</font> and other evolving business     strategies, and possible <font color="blue">organizational</font> restructuring could affect future     results</td>
    </tr>
    <tr>
      <td><font color="blue">The Company </font>monitors its business portfolio and <font color="blue">organizational</font>     structure and has made and <font color="blue">may continue</font> to make acquisitions, strategic     alliances, divestitures and changes to its <font color="blue">organizational</font> structure</td>
    </tr>
    <tr>
      <td><font color="blue">With     </font>respect to acquisitions, future results will be <font color="blue">affected by</font> the Company’s     ability to <font color="blue">quickly integrate</font> an acquired business and obtain the anticipated     synergies</td>
    </tr>
    <tr>
      <td>• The Company’s future results may be affected if the Company <font color="blue">generates less</font>     <font color="blue"><font color="blue">productivity</font> improvements than</font> estimated</td>
    </tr>
    <tr>
      <td><font color="blue">The Company </font><font color="blue">utilizes various</font>     tools,  such  as  Six  Sigma,  to  improve  operational <font color="blue">efficiency</font> and     <font color="blue">productivity</font></td>
    </tr>
    <tr>
      <td>There  can  be  no  assurance that all of the estimated     <font color="blue">productivity</font> improvements will be realized</td>
    </tr>
    <tr>
      <td>•  The  Company’s  future results may be <font color="blue">affected by</font> various legal and     <font color="blue">regulatory</font>  <font color="blue">proceedings</font>,  including those <font color="blue">involving product liability</font>,     <font color="blue">antitrust</font>,  <font color="blue">environmental</font> or other matters</td>
    </tr>
    <tr>
      <td>The outcome of these legal     <font color="blue">proceedings</font> may differ from the Company’s <font color="blue">expectations</font> because the outcomes     of <font color="blue">litigation</font>, including <font color="blue">regulatory</font> matters, are <font color="blue">often difficult</font> to reliably     predict</td>
    </tr>
    <tr>
      <td>Various factors or <font color="blue">development</font>s can lead the Company to change     current estimates of <font color="blue">liabilities</font> and related insurance <font color="blue">receivables</font> where     applicable, or make such estimates for matters <font color="blue">previously</font> not                                           9     ______________________________________________________________________         susceptible of reasonable estimates, such as a <font color="blue">significant</font> judicial ruling     or judgment, <font color="blue">significant</font> settlement, <font color="blue">significant</font> <font color="blue">regulatory</font> <font color="blue">development</font> or     changes  in  applicable  law</td>
    </tr>
    <tr>
      <td>A  future adverse ruling, settlement or     unfavorable <font color="blue">development</font> could result in <font color="blue">future charges</font> that could have a     material adverse effect on the Company’s results of <font color="blue">operations</font> or <font color="blue">cash flows</font>     in  any  particular  period</td>
    </tr>
    <tr>
      <td>A specific factor that <font color="blue">could increase</font> the     Company’s estimate of its future asbestos-related <font color="blue">liabilities</font> is the pending     <font color="blue">Congressional  </font><font color="blue">consideration</font> of <font color="blue">legislation</font> to reform asbestos-related     <font color="blue">litigation</font> and pertinent information <font color="blue">derived from</font> that process</td>
    </tr>
    <tr>
      <td>For a more     detailed discussion of the legal <font color="blue">proceedings</font> involving the Company and     associated  <font color="blue">accounting</font> estimates, see the discussion in Note 11 to the     <font color="blue">Consolidated Financial Statements </font>of this <font color="blue">Annual Report </font>on Form 10-K</td>
    </tr>
  </tbody>
</table>